glp 1 drug companies Market Overview: GLP-1 Agonists and the Obesity Market | Blog Healthcare and Pharma Shifts Driving
Description
India stands tall as the worlds pharmacy now poised to lead the GLP-1 revolution
Among the marketed large molecule injectable GLP-1 agonists, semaglutide, apart from weight-loss, is being studied for kidney disease and tirzepatide (a dual GLP-1 and GIP receptor agonist) is being evaluated for sleep apnea in Ph 3 clinical trials
ENCOURAGE THERMOGENIC ACTIVITY AND FAT UTILIZATION Features Paradoxine and Rauwolscine to help support thermogenesis, the bodys natural heat-production process that plays an important role in calorie burning and metabolic rate
Partly through these actions, GLP-1 receptor agonism was shown to reduce cardiovascular disease (CVD) in people with T2D with previous CVD or at high-risk thereof
The GLP-1 gold rush is getting a lot less photogenic
A study of health insurance claims found a 44% reduction in hospitalizations for GLP-1 users
